Brief: Coeptis Therapeutics Secures Exclusive Rights To Negotiate To Acquire Transformational Cell Therapy Platform To Enable Potent Combinatorial Immuno-Oncology Treatment Strategies
29/03/2023 14:54
March 29 (Reuters) - Coeptis Therapeutics Holdings Inc
COEP.O :
* COEPTIS THERAPEUTICS SECURES EXCLUSIVE RIGHTS TO NEGOTIATE
TO
ACQUIRE TRANSFORMATIONAL CELL THERAPY PLATFORM TO ENABLE POTENT
COMBINATORIAL IMMUNO-ONCOLOGY TREATMENT STRATEGIES
* COEPTIS THERAPEUTICS HOLDINGS INC - INTENDS TO IMMEDIATELY
COMMENCE ITS DUE DILIGENCE REVIEW OF VYGEN-BIO'S ASSETS
* COEPTIS THERAPEUTICS HOLDINGS INC - HAS OBTAINED EXCLUSIVE
RIGHT
TO NEGOTIATE TOWARDS ACQUISITION OF VYGEN-BIO, INC. OR ITS
ASSETS
* COEPTIS THERAPEUTICS HOLDINGS INC - DEPENDING ON RESULTS
OF ITS
DUE DILIGENCE ANALYSIS, CO TO TURN TO NEGOTIATION OF DEFINITIVE
DEAL DOCUMENTS
* COEPTIS THERAPEUTICS HOLDINGS INC - DEAL, IF FINALIZED,
WOULD
EXPAND UPON CO'S COLLABORATION WITH VYGEN-BIO
Further company coverage: COEP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Z Squared (Delaware)
See all newsBrief: Z Squared Inc. Signs Definitive Agreement To Acquire 100% Of Paradox Data And Its Union County Campus
Brief: Z Squared, Inc. To Acquire Majority Interest In Paradox Data And Its Union County Campus, A Next-Generation Data Center Development Targeting Up To 150 MW Of Firm Power
Brief: Z Squared, Inc. Enters $50 Million Committed Equity Forward Purchase Agreement To Support Ai Infrastructure Buildout
Brief: Z Squared Appoints Jon Najarian, Pete Najarian, Marc Lopresti And Jay Zapata To Newly Formed Advisory Board
Brief: Z Squared Announces Executive Leadership Appointments To Advance Ai Infrastructure Strategy